Trademark: 88281350
Status Date
Monday, November 21, 2022
Filing Date
Tuesday, January 29, 2019
Published for Opposition
Tuesday, August 20, 2019
Abandoned Date
Monday, November 21, 2022
40 Cryogenic preservation; Stem cell, cell, and tissue cryogenic preservation
5 Pre-packaged kits for use in regeneration and rejuvenation of patient cells for medical purposes, namely, kits comprising vials for containing cells, young donor cells, regeneration and rejuvenation media, small molecule and nucleotide-based therapeutics for cellular regeneration and rejuvenation, and transwell cell culture plates; Pharmaceutical preparations for regeneration and rejuvenation of patient cells; pharmaceutical preparations, namely, pharmaceutical preparations for use in regenerative medicine, oncology and treatment of infectious disease; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, antibodies, cell permeable and non-permeable fluorescent dyes, and radioisotopes
35 Business management and consultancy services; Business data analysis services in the field of healthcare; data processing and database management services for the healthcare industry
1 Chemical test kits for determining patient candidacy and condition for procedure for rejuvenating and regenerating patient cells in connection with clinical or medical laboratory use
44 Medical services; medical clinics; medical information; providing clinical testing information services for the diagnosis monitoring and treatment of disease for medical purposes; Medical services, namely, cell and stem cell mobilization, collection, isolation, processing, banking, implantation, explantation and transfer; liposuction; medical services in the fields of anti-aging, immunoncology, and vaccines; medical services for cell, stem cell and tissue rejuvenation and regeneration
10 Medical apparatus for use in patient cell collection and in treating patient cells in a transwell system to restore patient immune function and treat inflammatory-induced disorders, arthritis, atherosclerosis, breast cancer, cardiovascular disease, cataracts, chronic obstructive pulmonary disease, colorectal cancer, hypertension, osteoporosis, periodontitis, type 2 diabetes, immune dysfunction, Alzheimer's disease, leukemia, lymphoma, multiple sclerosis, Crohn's disease, HIV, influenza, pneumonia, lung cancer, melanoma, stroke, Parkinson's disease, and multiple drug resistant staphylococcus aureus ; apparatus for the regeneration and rejuvenation of stem cells, cells and tissue for medical purpose; human cell specimen collection kit comprising centrifuge tubes, absorbent cloth, and instructions, all for medical use
42 Data mining; data hosting services, namely, hosting of digital content on the internet for others; data hosting services, namely, hosting of healthcare and patient data on the internet for others
Nov 21, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Nov 21, 2022
Abandonment - No Use Statement Filed
Apr 21, 2022
Notice Of Approval Of Extension Request E-Mailed
Apr 20, 2022
Sou Extension 5 Granted
Apr 14, 2022
Sou Extension 5 Filed
Apr 20, 2022
Case Assigned To Intent To Use Paralegal
Apr 14, 2022
Sou Teas Extension Received
Oct 19, 2021
Notice Of Approval Of Extension Request E-Mailed
Oct 15, 2021
Sou Extension 4 Granted
Oct 15, 2021
Sou Extension 4 Filed
Oct 15, 2021
Sou Teas Extension Received
Mar 25, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 23, 2021
Sou Extension 3 Granted
Mar 23, 2021
Sou Extension 3 Filed
Mar 23, 2021
Sou Teas Extension Received
Oct 1, 2020
Notice Of Approval Of Extension Request E-Mailed
Sep 29, 2020
Sou Extension 2 Granted
Sep 29, 2020
Sou Extension 2 Filed
Sep 29, 2020
Sou Teas Extension Received
Apr 16, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 14, 2020
Sou Extension 1 Granted
Apr 14, 2020
Sou Extension 1 Filed
Apr 14, 2020
Sou Teas Extension Received
Oct 15, 2019
Noa E-Mailed - Sou Required From Applicant
Aug 20, 2019
Official Gazette Publication Confirmation E-Mailed
Aug 20, 2019
Published For Opposition
Aug 5, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Aug 5, 2019
Teas Change Of Owner Address Received
Jul 31, 2019
Notification Of Notice Of Publication E-Mailed
Jul 12, 2019
Assigned To Lie
Jul 1, 2019
Approved For Pub - Principal Register
Jun 18, 2019
Teas/Email Correspondence Entered
Jun 17, 2019
Correspondence Received In Law Office
Jun 17, 2019
Teas Response To Office Action Received
Apr 12, 2019
Notification Of Non-Final Action E-Mailed
Apr 12, 2019
Non-Final Action E-Mailed
Apr 12, 2019
Non-Final Action Written
Apr 10, 2019
Assigned To Examiner
Feb 21, 2019
New Application Office Supplied Data Entered
Feb 1, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
